These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Imbalance of the oxytocin-vasopressin system contributes to the neuropsychiatric phenotype in the BACHD mouse model of Huntington disease. Cheong RY; Tonetto S; von Hörsten S; Petersén Å Psychoneuroendocrinology; 2020 Sep; 119():104773. PubMed ID: 32590293 [TBL] [Abstract][Full Text] [Related]
23. Screening of therapeutic strategies for Huntington's disease in YAC128 transgenic mice. Gil-Mohapel JM CNS Neurosci Ther; 2012 Jan; 18(1):77-86. PubMed ID: 21501423 [TBL] [Abstract][Full Text] [Related]
24. Clinical features of Chinese patients with Huntington's disease carrying CAG repeats beyond 60 within HTT gene. Liu ZJ; Sun YM; Ni W; Dong Y; Shi SS; Wu ZY Clin Genet; 2014 Feb; 85(2):189-93. PubMed ID: 23398026 [TBL] [Abstract][Full Text] [Related]
25. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease. McBride JL; Ramaswamy S; Gasmi M; Bartus RT; Herzog CD; Brandon EP; Zhou L; Pitzer MR; Berry-Kravis EM; Kordower JH Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9345-50. PubMed ID: 16751280 [TBL] [Abstract][Full Text] [Related]
26. A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease. Cummings DM; Alaghband Y; Hickey MA; Joshi PR; Hong SC; Zhu C; Ando TK; André VM; Cepeda C; Watson JB; Levine MS J Neurophysiol; 2012 Jan; 107(2):677-91. PubMed ID: 22072510 [TBL] [Abstract][Full Text] [Related]
27. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Reddy PH; Williams M; Charles V; Garrett L; Pike-Buchanan L; Whetsell WO; Miller G; Tagle DA Nat Genet; 1998 Oct; 20(2):198-202. PubMed ID: 9771716 [TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of the miniature pig Huntington's disease gene homolog: evidence for conservation and polymorphism in the CAG triplet repeat. Matsuyama N; Hadano S; Onoe K; Osuga H; Showguchi-Miyata J; Gondo Y; Ikeda JE Genomics; 2000 Oct; 69(1):72-85. PubMed ID: 11013077 [TBL] [Abstract][Full Text] [Related]
30. Memory deficits in the transgenic rat model of Huntington's disease. Zeef DH; van Goethem NP; Vlamings R; Schaper F; Jahanshahi A; Hescham S; von Hörsten S; Prickaerts J; Temel Y Behav Brain Res; 2012 Feb; 227(1):194-8. PubMed ID: 22101303 [TBL] [Abstract][Full Text] [Related]
31. Transgenic models of Huntington's disease. Sathasivam K; Hobbs C; Mangiarini L; Mahal A; Turmaine M; Doherty P; Davies SW; Bates GP Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):963-9. PubMed ID: 10434294 [TBL] [Abstract][Full Text] [Related]
32. Lessons from animal models of Huntington's disease. Rubinsztein DC Trends Genet; 2002 Apr; 18(4):202-9. PubMed ID: 11932021 [TBL] [Abstract][Full Text] [Related]